Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4643012
Max Phase: Preclinical
Molecular Formula: C75H95N12O17S+
Molecular Weight: 1468.72
Molecule Type: Unknown
Associated Items:
ID: ALA4643012
Max Phase: Preclinical
Molecular Formula: C75H95N12O17S+
Molecular Weight: 1468.72
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O)C1CCCC1
Standard InChI: InChI=1S/C75H94N12O17S/c1-6-54(80-71(99)59(38-45-21-11-8-12-22-45)84-70(98)58(78-43(2)89)37-44-19-9-7-10-20-44)67(95)86-65(46-23-13-14-24-46)73(101)83-56(26-16-18-36-87(3,4)5)68(96)85-60(42-88)72(100)82-57(33-34-63(92)93)69(97)81-55(66(76)94)25-15-17-35-77-75(105)79-47-27-30-50(53(39-47)74(102)103)64-51-31-28-48(90)40-61(51)104-62-41-49(91)29-32-52(62)64/h7-12,19-22,27-32,39-41,46,54-60,65,88H,6,13-18,23-26,33-38,42H2,1-5H3,(H14-,76,77,78,79,80,81,82,83,84,85,86,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,105)/p+1/t54-,55-,56-,57-,58-,59-,60-,65-/m0/s1
Standard InChI Key: KNTVOGGZZGGXNN-JSWZDDDHSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1468.72 | Molecular Weight (Monoisotopic): 1467.6653 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):